A study of treatment of lung diseases with conditioned medium

Not Applicable

Recruiting

• Conditions: lung disease; D008171

• Registration Number: JPRN-jRCT1051220090
• Lead Sponsor: Inami Norihito Norihito

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-09-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1. Patients who did not have a satisfactory therapeutic effect with standard treatment by a respiratory physician
2. Patients who do not wish to be treated with the drugs used in standard treatment due to concerns about side effects, etc., and those who have been judged by the doctor that chronic pain treatment with conditioned medium is optimal.

Target patients who meet the following criteria.
1. 18 years old and over
2. Have normal consent ability
3. Those who have been diagnosed with diffuse panbronchioles, interstitial lung disease, chronic obstructive pulmonary disease (COPD) or have symptoms of respiratory distress and have lung disease that the doctor has determined to be appropriate treatment. direction
4. Patients who can obtain their free will consent in writing
5. Patients whose doctor have recognized the need for treatment

Exclusion Criteria

Patient who meet any of the following conditions are excluded
1. Have a history of or suspected of dementia
2. Users of narcotics or stimulants
3. Pregnant, breastfeeding
4. Judged unsuitable by the doctor

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in KL-6.Changes in High-sensitivity CRP, galectin-3, adiponectin, total antioxidant capacity, grip strength, body composition (weight, muscle mass).

Secondary Outcome Measures

Name	Time	Method
subjective symptoms, etc.